Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Risk classification for prostate cancer (PCa) aggressiveness and underlying mechanisms remain inadequate. Interactions between single nucleotide polymorphisms (SNPs) may provide a solution to fill these gaps. To identify SNP-SNP interactions in the four pathways (the angiogenesis-, mitochondria-, miRNA-, and androgen metabolism-related pathways) associated with PCa aggressiveness, we tested 8587 SNPs for 20,729 cases from the PCa consortium. We identified 3 KLK3 SNPs, and 1083 (P 

Original publication

DOI

10.1038/s41598-021-85169-7

Type

Journal article

Journal

Sci Rep

Publication Date

29/04/2021

Volume

11

Keywords

Biomarkers, Tumor, Epistasis, Genetic, Genetic Predisposition to Disease, Genotype, Humans, Kallikreins, Male, Polymorphism, Single Nucleotide, Prostate-Specific Antigen, Prostatic Neoplasms